An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results